Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Cognes Medical Solutions AB
AB
Active
Org 5592675580
Tuves Väg 13, 254 78
Domsten
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2020
0 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Cognes Medical Solutions AB
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2021
-1M
2022
-1M
2023
0M
2024
Income statement
SEK thousands
Item
2021
2022
2023
2024
Revenue
0
0
0
14
Staff expenses
—
−485
—
−1 040
EBITDA
—
−628
−549
−100
Depreciation & amort.
−0
—
−0
—
EBIT
0
−628
−549
−100
Net financials
—
−1
−31
−31
Profit before tax
0
−629
−580
—
Tax
−0
—
−0
—
Net profit
0
−629
−580
−131
Balance sheet
SEK thousands
Item
2021
2022
2023
2024
Total assets
25
212
968
2 115
Equity
25
86
463
1 685
Long-term debt
0
106
250
78
Short-term debt
0
19
255
352
Total debt
—
126
505
430
Financial ratios
5-year trend
EBITDA margin
-713.5%
This company
15.8%
Market median
-4616% vs market
2021
2024
Equity ratio
79.7%
This company
38.2%
Market median
+109% vs market
2021
2024
Return on equity
-7.8%
This company
18.4%
Market median
-142% vs market
2021
2024
Net profit margin
-935.0%
This company
8.1%
Market median
-11643% vs market
2021
2024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
2021
2024
Debt / equity
0.26×
This company
0.62×
Market median
+58% vs market
2021
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2020-08-01 – 2021-12-31
View
PDF
More on Cognes Medical Solutions AB
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
